The science of wound care has advanced significantly over the past few years in terms of material and technology. Technology can now be embedded into supporting and dressing materials used in wound care management. It has enabled remote monitoring of the healing, promotes adherence to the treatment plan, predictive analytics through image and data processing, and delivers timely insights to providers. It can lead to improved treatment and care experience along with bringing down the cost-of-care to the health ecosystem.
Virtusa is a pioneer in connected care technology with the capability to deliver an end-to-end solution. We leverage our built-in accelerators for rapid prototyping, value, evaluation, and delivery of solutions faster to market while ensuring HIPAA compliance. A UK-based medical device company partnered with Virtusa to develop an Intelligent wearable device (bandage) for patients suffering from Diabetic Foot Ulcer (DFU) and a necessary application for HCPs (healthcare professionals) to monitor patient adherence to therapy.
The International Diabetes Federation estimates around 463 million people were living with diabetes in 2019 globally, and in 2045 it will be more than 700 million. Approximately 25% of them will be affected by DFU. DFU is an open sore or wound commonly located on the bottom of the foot. It presents significant reductions in quality of life for those affected and a substantial clinical and economic burden toon healthcare systems worldwide. For optimum healing, ulcers, especially those on the bottom of the foot, must be “off-loaded”.
Virtusa designed an underlying software, using IoT, Image processing & data analytics, for wound care customer wearable bandages. It supports HCPs (principally podiatrists and Nurses) in assessing the compliance of patients with a diagnosed and treated Diabetic Foot Ulcer (DFU) to a prescribed therapy – Off-loading – to facilitate better DFU wound healing outcomes.